Finnish devicemaker ArcDia has earned the CE mark for its automated COVID-19 diagnostic test.
The point-of-care test uses a swab sample to directly detect the virus. It is available for high-capacity rapid testing or as part of a respiratory test panel that identifies 11 common respiratory pathogens.
The test is cleared for use on the company’s mariPOC system. The bench-top system can analyze 300 COVID-19 samples a day, a capacity “high enough for most outpatient and emergency care units,” said ArcDia’s CEO Vesa Kemppainen.